The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Lebovits Chaim since 2024.
This trader's CIK number is 1406302.
At the time of last reporting, Lebovits Chaim was the President & CEO of Brainstorm Cell Therapeutics Inc.. (stock ticker symbol BCLI).
Also see all insider trading activities at Brainstorm Cell Therapeutics Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | BCLI | 23,836 | $11,307 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-09-30 | BCLI | Buy | 22,000 | .23 | 5,016 |
| 2024-10-01 | BCLI | Buy | 1,836 | 3.43 | 6,291 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Lebovits Chaim (President & CEO of Brainstorm Cell Therapeutics Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.